122 related articles for article (PubMed ID: 35818749)
1. Lymphoproliferative disease detected by breast cancer screening.
Luttwak E; Segman Y; Saban M; Gutwein O; Avivi I; Perry C; Filiavich A; Sarid N
J Med Screen; 2022 Dec; 29(4):255-259. PubMed ID: 35818749
[TBL] [Abstract][Full Text] [Related]
2. Lymphoproliferative disorders in multiple primary cancers.
Demirci U; Ozdemir N; Benekli M; Babacan NA; Cetin B; Baykara M; Coskun U; Zengin N; Buyukberber S
Asian Pac J Cancer Prev; 2012; 13(1):383-6. PubMed ID: 22502706
[TBL] [Abstract][Full Text] [Related]
3. Cancer Therapy-associated Lymphoproliferative Disorders: An Under-recognized Type of Immunodeficiency-associated Lymphoproliferative Disorder.
Pina-Oviedo S; Miranda RN; Medeiros LJ
Am J Surg Pathol; 2018 Jan; 42(1):116-129. PubMed ID: 29112013
[TBL] [Abstract][Full Text] [Related]
4. Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Kabasawa N; Shiozawa E; Murai S; Homma M; Uesugi Y; Matsui T; Nakata A; Shimada S; Sasaki Y; Baba Y; Watanuki M; Arai N; Fujiwara S; Kawaguchi Y; Tsukamoto H; Uto Y; Yanagisawa K; Hattori N; Sakai H; Harada H; Nakamaki T; Takimoto M; Yamochi-Onizuka T
J Clin Exp Hematop; 2021; 61(3):120-125. PubMed ID: 34511544
[TBL] [Abstract][Full Text] [Related]
5. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant.
Chadburn A; Chen JM; Hsu DT; Frizzera G; Cesarman E; Garrett TJ; Mears JG; Zangwill SD; Addonizio LJ; Michler RE; Knowles DM
Cancer; 1998 May; 82(10):1978-87. PubMed ID: 9587133
[TBL] [Abstract][Full Text] [Related]
6. Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.
Nakano K; Saito K; Nawata A; Hanami K; Kubo S; Miyagawa I; Fujino Y; Nakayamada S; Tanaka Y
Mod Rheumatol; 2021 Jan; 31(1):94-100. PubMed ID: 32159414
[TBL] [Abstract][Full Text] [Related]
7. Management of febrile neutropenia--a German prospective hospital cost analysis in lymphoproliferative disorders, non-small cell lung cancer, and primary breast cancer.
Ihbe-Heffinger A; Paessens BJ; von Schilling C; Shlaen M; Gottschalk N; Berger K; Bernard R; Kiechle M; Peschel C; Jacobs VR
Onkologie; 2011; 34(5):241-6. PubMed ID: 21577029
[TBL] [Abstract][Full Text] [Related]
8. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China.
Wang X; Liang Y; Yang Y; Li W; Wang G; Wang S; Li Y; Zhang M
J Dermatol; 2021 Sep; 48(9):1315-1326. PubMed ID: 33982815
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node surgery for staging of breast carcinoma in patients with lymphoproliferative disease.
Dy BM; Reynolds CA; Wahner-Roedler DL; Boughey JC
Am Surg; 2010 Dec; 76(12):1423-5. PubMed ID: 21265361
[TBL] [Abstract][Full Text] [Related]
10. Lymphoproliferative disorders in patients with chronic myeloproliferative neoplasms: A systematic review.
Marchetti M; Carobbio A; Capitoni E; Barbui T
Am J Hematol; 2018 May; 93(5):698-703. PubMed ID: 29377227
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations in
Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP
Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407
[TBL] [Abstract][Full Text] [Related]
12. Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders.
Watanabe M; Kanda J; Hishizawa M; Nishikori M; Kondo T; Yamashita K; Takaori-Kondo A
Ann Hematol; 2020 Jul; 99(7):1565-1573. PubMed ID: 32436013
[TBL] [Abstract][Full Text] [Related]
13. Cytologic findings in posttransplant lymphoproliferative disease.
Davey DD; Gulley ML; Walker WP; Zaleski S
Acta Cytol; 1990; 34(3):304-10. PubMed ID: 2343685
[TBL] [Abstract][Full Text] [Related]
14. The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis.
Tokuhira M; Tabayashi T; Tanaka Y; Takahashi Y; Kimura Y; Tomikawa T; Anan-Nemoto T; Momose S; Higashi M; Okuyama A; Watanabe R; Amano K; Tamaru JI; Kizaki M
J Clin Exp Hematop; 2017; 56(3):165-169. PubMed ID: 28331131
[TBL] [Abstract][Full Text] [Related]
15. Detection of gammopathy by serum protein electrophoresis for predicting and managing therapy of lymphoproliferative disorder in 911 recipients of liver transplants.
Lemoine A; Pham P; Azoulay D; Saliba F; Emile JF; Saffroy R; Broet P; Bismuth H; Samuel D; Debuire B
Blood; 2001 Sep; 98(5):1332-8. PubMed ID: 11520779
[TBL] [Abstract][Full Text] [Related]
16. Abdominal-pelvic lymphoproliferative disease after lung transplantation: presentation and outcome.
Hachem RR; Chakinala MM; Yusen RD; Lynch JP; Aloush AA; Patterson GA; Trulock EP
Transplantation; 2004 Feb; 77(3):431-7. PubMed ID: 14966421
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
18. Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil.
Ferreira CR; Zhao S; Sanches JA; Miyashiro D; Cury-Martins J; Azevedo RS; Zerbini MCN; Natkunam Y; Gratzinger D
Diagn Pathol; 2019 Oct; 14(1):115. PubMed ID: 31640798
[TBL] [Abstract][Full Text] [Related]
19. Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate.
Saito S; Kaneko Y; Yamaoka K; Tokuhira M; Takeuchi T
Rheumatology (Oxford); 2017 Jun; 56(6):940-946. PubMed ID: 28165538
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of clinical methotrexate-related lymphoproliferative disorders.
Tokuhira M; Saito S; Suzuki K; Higashi M; Momose S; Shimizu T; Mori T; Kimura Y; Amano K; Okamoto S; Takeuchi T; Tamaru JI; Kizaki M
Leuk Lymphoma; 2019 Oct; 60(10):2508-2515. PubMed ID: 30947579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
